Research Output per year
Fingerprint Dive into the research topics where Silvia Damian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
letrozole
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Paclitaxel
Medicine & Life Sciences
Anthracyclines
Medicine & Life Sciences
Safety
Medicine & Life Sciences
Salivary Glands
Medicine & Life Sciences
L-Lactate Dehydrogenase
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2016 2019
- 184 Citations
- 1 h-Index
- 6 Article
Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-l1 monoclonal antibodies
Cona, M. S., Lecchi, M., Cresta, S., Damian, S., Del Vecchio, M., Necchi, A., Poggi, M. M., Raggi, D., Randon, G., Ratta, R., Signorelli, D., Vernieri, C., de Braud, F., Verderio, P. & Di Nicola, M., Feb 2019, In : Cancers. 11, 2, 223.Research output: Contribution to journal › Article
Open Access
L-Lactate Dehydrogenase
Monoclonal Antibodies
CD274 Antigen
Area Under Curve
Neoplasms
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study
Mariani, G., Galli, G., Cavalieri, S., Valagussa, P., Bianchi, G. V., Capri, G., Cresta, S., Ferrari, L., Damian, S., Duca, M., de Braud, F. & Moliterni, A., Mar 1 2019, In : Breast Journal. 25, 2, p. 237-242 6 p.Research output: Contribution to journal › Article
Anthracyclines
Breast Neoplasms
Drug Therapy
Paclitaxel
Methotrexate
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer
Schöffski, P., Cresta, S., Mayer, I. A., Wildiers, H., Damian, S., Gendreau, S., Rooney, I., Morrissey, K. M., Spoerke, J. M., Ng, V. W., Singel, S. M. & Winer, E., Sep 5 2018, In : Breast Cancer Research. 20, 1, p. 109Research output: Contribution to journal › Article
letrozole
Paclitaxel
Breast Neoplasms
Maximum Tolerated Dose
Phosphatidylinositol 3-Kinase
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study
Cohen, R. B., Delord, J-P., Doi, T., Piha-Paul, S. A., Liu, S. V., Gilbert, J., Algazi, A. P., Damian, S., Hong, R-L., Le Tourneau, C., Day, D., Varga, A., Elez, E., Wallmark, J., Saraf, S., Thanigaimani, P., Cheng, J. & Keam, B., Feb 21 2018, In : American Journal of Clinical Oncology.Research output: Contribution to journal › Article
Salivary Glands
Carcinoma
Ligands
Therapeutics
Licensure
184
Citations
(Scopus)
Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: Combined results from two phase I trials (ALKA-372-001 and STARTRK-1)
Drilon, A., Siena, S., Ou, S. H. I., Patel, M., Ahn, M. J., Lee, J., Bauer, T. M., Farago, A. F., Wheler, J. J., Liu, S. V., Doebele, R., Giannetta, L., Cerea, G., Marrapese, G., Schirru, M., Amatu, A., Bencardino, K., Palmeri, L., Sartore-Bianchi, A., Vanzulli, A. & 15 others, , Apr 1 2017, In : Cancer Discovery. 7, 4, p. 400-409 10 p.Research output: Contribution to journal › Article
Gene Fusion
Safety
Central Nervous System Diseases
Neoplasms
Gene Targeting